Related references
Note: Only part of the references are listed.Prospective Analysis of Human Cytomegalovirus DNAemia and Specific CD8+ T Cell Responses in Lung Transplant Recipients
L. Weseslindtner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Human Cytomegalovirus-Specific T-Cell Immune Reconstitution in Preemptively Treated Heart Transplant Recipients Identifies Subjects at Critical Risk for Infection
Davide Abate et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipients
Manisha Patel et al.
PEDIATRIC TRANSPLANTATION (2012)
Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia
Luiz F. Lisboa et al.
TRANSPLANTATION (2012)
Virologic and Immunologic Monitoring of Cytomegalovirus to Guide Preemptive Therapy in Solid-Organ Transplantation
G. Gerna et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections
Emilia Genini et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
Primary Cytomegalovirus Phosphoprotein 65-Specific CD8+ T-Cell Responses and T-bet Levels Predict Immune Control During Early Chronic Infection in Lung Transplant Recipients
Matthew R. Pipeling et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients
Corinna La Rosa et al.
TRANSPLANT INTERNATIONAL (2011)
Evalvation and Significance of Cytomegalovirus-Specific Cellular Immune Response in Lung Transplant Recipients
C. Costa et al.
TRANSPLANTATION PROCEEDINGS (2011)
The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
A. Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus After Lung Transplantation
Scott M. Palmer et al.
ANNALS OF INTERNAL MEDICINE (2010)
CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study
Fredrik Sund et al.
CLINICAL TRANSPLANTATION (2010)
Narrowing of T-cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients
Katherine K. Wynn et al.
IMMUNOLOGY AND CELL BIOLOGY (2010)
Evaluation of Cytomegalovirus (CMV)-Specific T Cell Immune Reconstitution Revealed That Baseline Antiviral Immunity, Prophylaxis, or Preemptive Therapy but not Antithymocyte Globulin Treatment Contribute to CMV-Specific T Cell Reconstitution in Kidney Transplant Recipients
Davide Abate et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+and CD8+T cells in kidney allograft recipients at risk of CMV infection
Albert J. Eid et al.
TRANSPLANT INTERNATIONAL (2010)
Extended Valganciclovir Prophylaxis in D+/R- Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study
Atul Humar et al.
TRANSPLANTATION (2010)
International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2010)
Monitoring Cytomegalovirus T-Cell Immunity in Small Bowel/Multivisceral Transplant Recipients
A. Chiereghin et al.
TRANSPLANTATION PROCEEDINGS (2010)
Quantiferon-CMV Test in Prediction of Cytomegalovirus Infection After Kidney Transplantation
A. Lochmanova et al.
TRANSPLANTATION PROCEEDINGS (2010)
Cytomegalovirus in Solid Organ Transplant Recipients
A. Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients
D. Kumar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients
A. Asberg et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Experience With Immune Monitoring in Lung Transplant Recipients: Correlation of Low Immune Function With Infection
Shahid Husain et al.
TRANSPLANTATION (2009)
The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients
M. Stern et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Linking CMV serostatus to episodes of CMV reactivation following lung transplantation by measuring CMV-specific CD8+ T-cell immunity
G. P. Westall et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
PD-1 expression and IL-2 loss of cytomegalovirus-specific T cells correlates with viremia and reversible functional anergy
U. Sester et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Investigation of promoter variations in dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN) (CD209) and their relevance for human cytomegalovirus reactivation and disease after allogeneic stem-cell transplantation
M. Mezger et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients
Adrian Egli et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Relationship between toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation
Supha Kijpittayarit et al.
CLINICAL INFECTIOUS DISEASES (2007)
Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease
Corinna La Rosa et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON (R)-CMV
S. Walker et al.
TRANSPLANT INFECTIOUS DISEASE (2007)
Monitoring of human cytomegalovirus-specific CD4+ and CD8+ T-cell immunity in patients receiving solid organ transplantation
G. Gerna et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects
AW Sylwester et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation
U Sester et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients
A Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells
T Bunde et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
T cells and viral persistence: lessons from diverse infections
P Klenerman et al.
NATURE IMMUNOLOGY (2005)
Cellular immune responses to cytomegalovirus in renal transplant recipients
R Radha et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
C Paya et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection
M Sester et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease
A Humar et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Share Paper
